STING inhibition has been shown to attenuate fibrosis in human and mouse hypertrophic cardiomyopathy [84] as well as in experimental models of kidney, lung, and liver fibrosis [85, 86]. This evidence concerns the gene STING1 and hypertrophic cardiomyopathy.